Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Qiuhong Qian"'
Autor:
Hong Lv, Jing Yu, Xingjia Qian, Jun Shu, Qiuhong Qian, Luhong Shen, Dongfang Shi, Zhengzheng Tao, Guiqin Fan, Bufeng Zhuang, Bing Lu
Publikováno v:
iScience, Vol 27, Iss 6, Pp 109667- (2024)
Summary: Our work aimed to investigate the interactive roles of transforming growth factor β1 (TGF-β1), ubiquitin-specific-processing protease 7 (USP7), and Yes-associated protein (YAP) in ferroptosis during sepsis-secondary acute lung injury (ALI)
Externí odkaz:
https://doaj.org/article/d621cbf0bb354273a57cb0a446b1727f
Publikováno v:
Gynecologic Oncology Reports, Vol 48, Iss , Pp 101228- (2023)
Objective: For early-stage cervical cancer patients experiencing radical surgery, postoperative radiotherapy was recommended for patients with a combination of intermediate-risk factors. However, there was no consensus on whether to administer concur
Externí odkaz:
https://doaj.org/article/6c0885bebfb74d1c82b965a1dda0247e
Autor:
Xiao Huo, Hengzi Sun, Qiuhong Qian, Xiangwen Ma, Peng Peng, Mei Yu, Ying Zhang, Jiaxin Yang, Dongyan Cao, Ting Gui, Keng Shen
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
BackgroundOvarian cancer has the highest mortality rate among gynecologic cancers, and most patients are diagnosed in advanced stages. Enhancer of zeste homolog 2 (EZH2) is a major tumor marker and an effective therapeutic target for ovarian cancer,
Externí odkaz:
https://doaj.org/article/5b23e49b02d24f618c7fb95db46d8034
Publikováno v:
Journal of Ovarian Research, Vol 11, Iss 1, Pp 1-9 (2018)
Abstract Background B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) might be an appropriate biomarker in the management of epithelial ovarian cancer (EOC). However, the biological role of BMI1 and its relevant molecular mechan
Externí odkaz:
https://doaj.org/article/339b8d2bcd8f40269fa3d913a780a493
Publikováno v:
Japanese Journal of Clinical Oncology. 53:122-129
Objective Studies determining which early-stage cervical cancer patients with high-risk factors benefit from consolidation chemotherapy after postoperative concurrent chemoradiotherapy (CCRT) are limited and inconsistent. The aim of this study was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ce34225d0e30c1d2b777473220545ea
https://doi.org/10.1093/jjco/hyac170
https://doi.org/10.1093/jjco/hyac170
Autor:
Sai Han, Junhua Zhang, Yu Sun, Lu Liu, Lingyu Guo, Chunru Zhao, Jiaxin Zhang, Qiuhong Qian, Baoxia Cui, Youzhong Zhang
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 23; Pages: 7155
Objective: The process of normal cervix changing into high grade squamous intraepithelial lesion (HSIL) and invasive cervical cancer is long and the mechanisms are still not completely clear. This study aimed to reveal the protein profiles related to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e0826750061021bebecc47c3e51a76a
https://doi.org/10.3390/jcm11237155
https://doi.org/10.3390/jcm11237155
Autor:
Lu Liu, Qiuhong Qian, Baoxia Cui, Youzhong Zhang, Hongli Liu, Sai Han, Xuewu You, Xuejiao Shi, Ying Wang, Yu Sun, Yana Ma
Publikováno v:
Cancer Management and Research. 11:8081-8093
Background It is unclear whether low density lipoprotein receptor-related protein 11 (LRP11), a newly found lipoprotein receptor regulatory protein, has the carcinogenic effects in cervical cancer. Methods Bioinformatics analysis, immunohistochemical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd163c9544f4145f8951f1aa989897c1
https://doi.org/10.2147/cmar.s211912
https://doi.org/10.2147/cmar.s211912
Autor:
Mei Yu, Hengzi Sun, Xiangwen Ma, Jiaxin Yang, Ting Gui, Dongyan Cao, Ying Zhang, Qiuhong Qian, Keng Shen, Peng Peng, Xiao Huo
Publikováno v:
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
Background Ovarian cancer has the highest mortality rate among gynecologic cancers, and most patients are diagnosed in advanced stages. Enhancer of zeste homolog 2 (EZH2) is a major tumor marker and an effective therapeutic target for ovarian cancer,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed3ab2b0f18828d59e50e651136d542c
https://pubmed.ncbi.nlm.nih.gov/33163485
https://pubmed.ncbi.nlm.nih.gov/33163485
Autor:
Jing Jin, Qian Chen, Liju Zong, Li Chen, Qiuhong Qian, Xingsheng Yang, Yana Ma, Youzhong Zhang, Baoxia Cui, Xuejiao Shi, Jingjing Zhang, Sai Han, Lu Liu, Ying Wang
Publikováno v:
Journal of Cancer
B7-H3, which has been reported to be a co-regulatory ligand of the B7 family, can suppress T cell-mediated immunity and has also been reported to be expressed in many malignancies. In this study, we found that B7-H3 was primarily expressed in the cyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be12507bf7961b3bd65c36316d55e5ed
http://europepmc.org/articles/PMC6072813
http://europepmc.org/articles/PMC6072813
Publikováno v:
Oncology Reports. 38:1043-1050
B7-H3 is an immune regulatory molecule whose aberrant expression in tumors is associated with adverse outcomes. Upregulation of B7-H3 may promote tumor cell proliferation and metastasis in vitro, but the role of B7-H3 in cervical cancer has not yet b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1265014aa077a961f3819f1e4ee3c1f2
https://doi.org/10.3892/or.2017.5730
https://doi.org/10.3892/or.2017.5730